Table 2.
Population—distribution of eHealth trials among the 3 disease groups of interest.
| Disease groups | Patient distribution, n (%) | ||
| Asthma or COPDa(n=16) | |||
|
|
Asthma | 13 (21) | |
|
|
COPD | 2 (3) | |
|
|
Both | 1 (2) | |
| CVDb(n=31) | |||
|
|
Hypertension | 18 (28) | |
|
|
CHDc | 7 (11) | |
|
|
Heart failure | 2 (3) | |
|
|
Atrial fibrillation | 2 (3) | |
|
|
Mix | 1 (2) | |
|
|
Patients on OACd | 1 (2) | |
| CVD and diabetes (n=3) | |||
|
|
Hypertension and diabetes | 3 (5) | |
| Diabetes (n=13) | |||
|
|
Type 2 diabetes | 9 (14) | |
|
|
Type 1 diabetes | 2 (3) | |
|
|
Uncontrolled diabetes | 2 (3) | |
aCOPD: chronic obstructive pulmonary disease.
bCVD: cardiovascular disease.
cCHD: coronary heart disease.
dOAC: oral anticoagulant.